In a fiercely competitive fast-food landscape, Domino's Pizza is navigating the challenge of sustaining its growth trajectory. The company's strategy hinges on ...

Wall Street's attention has turned to biotech firm Ocugen as it advances its gene therapy programs for inherited retinal diseases. While clinical development pr ...

Apple's operational landscape this spring is anything but routine. The technology giant is simultaneously advancing on multiple strategic fronts, from regulator ...

The global leader in semiconductor foundry services, Taiwan Semiconductor Manufacturing Company (TSMC), continues to be a primary beneficiary of the explosive d ...

Shares of the telehealth provider Hims & Hers Health have experienced a dramatic rally following a major strategic reversal and the resolution of a legal di ...

Bloom Energy has captured the attention of investors focused on AI infrastructure, with its stock surging more than 600% since the start of 2025. The company's ...

The performance of Armour Residential REIT is currently navigating a market landscape dominated by expectations surrounding ...

The technology giant Meta is charting a course toward greater independence in artificial intelligence hardware, but ...

Viking Therapeutics has progressed its obesity treatment program, centered on the drug candidate VK2735, into the pivotal Phase 3 stage of development. The comp ...

Palantir announces key AI partnerships with Nvidia and GE Aerospace to drive commercial growth and reduce reliance on government contracts, despite high valuation.

Ultragenyx Pharmaceutical has reported significant progress in its clinical development for a rare genetic disorder. New data from a Phase 3 trial investigating ...

The global pivot toward energy security is casting a powerful spotlight on NAC Kazatomprom, the world's largest uranium ...